A common pharmaceutical market in the Eurasian Union may not begin functioning on time
In the course of a recent conference devoted to effective development of markets within the Customs Union multiple experts shared doubts in the ability to develop the required regulatory framework by January 1, 2016. It was suggested that in order to achieve real regulatory harmonization a simple unification of registration, pricing and drug circulation is not sufficient. Full-scale integration is impossible without developing common treatment guidelines and protocols, as well as equal access to drugs in all countries involved.
Source: Pharmvestnik